2025. Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s573. DOI:https://doi.org/10.25251/skin.10.supp.573.